These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1656591)

  • 21. Domain structure of vaccinia virus mRNA capping enzyme. Activity of the Mr 95,000 subunit expressed in Escherichia coli.
    Shuman S; Morham SG
    J Biol Chem; 1990 Jul; 265(20):11967-72. PubMed ID: 2164023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reaction mechanism of mRNA guanylyltransferase from rat liver: isolation and characterization of a guanylyl-enzyme intermediate.
    Mizumoto K; Kaziro Y; Lipmann F
    Proc Natl Acad Sci U S A; 1982 Mar; 79(6):1693-7. PubMed ID: 6281779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Silencing and complementation of reovirus core protein mu2: functional correlations with mu2-microtubule association and differences between virus- and plasmid-derived mu2.
    Carvalho J; Arnold MM; Nibert ML
    Virology; 2007 Aug; 364(2):301-16. PubMed ID: 17451769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Translation of reovirus RNA species m1 can initiate at either of the first two in-frame initiation codons.
    Roner MR; Roner LA; Joklik WK
    Proc Natl Acad Sci U S A; 1993 Oct; 90(19):8947-51. PubMed ID: 8415636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Guanylyltransferase and RNA 5'-triphosphatase activities of the purified expressed VP4 protein of bluetongue virus.
    Martinez-Costas J; Sutton G; Ramadevi N; Roy P
    J Mol Biol; 1998 Jul; 280(5):859-66. PubMed ID: 9671555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crystallization of the reovirus type 3 Dearing core. Crystal packing is determined by the lambda 2 protein.
    Coombs KM; Fields BN; Harrison SC
    J Mol Biol; 1990 Sep; 215(1):1-5. PubMed ID: 2398494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reovirus enzymes that modify messenger RNA are inhibition by perturbation of the lambda proteins.
    Morgan EM; Kingsbury DW
    Virology; 1981 Sep; 113(2):565-72. PubMed ID: 6267798
    [No Abstract]   [Full Text] [Related]  

  • 28. A yeast-based genetic system for functional analysis of viral mRNA capping enzymes.
    Ho CK; Martins A; Shuman S
    J Virol; 2000 Jun; 74(12):5486-94. PubMed ID: 10823853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complete nucleotide sequence of reovirus L2 gene and deduced amino acid sequence of viral mRNA guanylyltransferase.
    Seliger LS; Zheng K; Shatkin AJ
    J Biol Chem; 1987 Dec; 262(34):16289-93. PubMed ID: 2824487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional domains of vaccinia virus mRNA capping enzyme. Analysis by limited tryptic digestion.
    Shuman S
    J Biol Chem; 1989 Jun; 264(16):9690-5. PubMed ID: 2542318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. mRNA capping enzymes are masked in reovirus progeny subviral particles.
    Skup D; Millward S
    J Virol; 1980 May; 34(2):490-6. PubMed ID: 6246277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Virus-specific mRNA capping enzyme encoded by hepatitis E virus.
    Magden J; Takeda N; Li T; Auvinen P; Ahola T; Miyamura T; Merits A; Kääriäinen L
    J Virol; 2001 Jul; 75(14):6249-55. PubMed ID: 11413290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Localization of a C-terminal region of lambda2 protein in reovirus cores.
    Luongo CL; Dryden KA; Farsetta DL; Margraf RL; Severson TF; Olson NH; Fields BN; Baker TS; Nibert ML
    J Virol; 1997 Oct; 71(10):8035-40. PubMed ID: 9311901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization and structural localization of the reovirus lambda 3 protein.
    Cashdollar LW
    Res Virol; 1994; 145(5):277-85. PubMed ID: 7839005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The reovirus mutant tsA279 has temperature-sensitive lesions in the M2 and L2 genes: the M2 gene is associated with decreased viral protein production and blockade in transmembrane transport.
    Hazelton PR; Coombs KM
    Virology; 1995 Feb; 207(1):46-58. PubMed ID: 7871752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cloning, expression, and characterization of avian reovirus guanylyltransferase.
    Hsiao J; Martínez-Costas J; Benavente J; Vakharia VN
    Virology; 2002 May; 296(2):288-99. PubMed ID: 12069527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Covalent guanylyl intermediate formed by HeLa cell mRNA capping enzyme.
    Wang D; Furuichi Y; Shatkin AJ
    Mol Cell Biol; 1982 Aug; 2(8):993-1001. PubMed ID: 6290877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The sequences of the reovirus serotype 1, 2, and 3 L1 genome segments and analysis of the mode of divergence of the reovirus serotypes.
    Wiener JR; Joklik WK
    Virology; 1989 Mar; 169(1):194-203. PubMed ID: 2922925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Purification of mRNA guanylyltransferase from vaccinia virions.
    Monroy G; Spencer E; Hurwitz J
    J Biol Chem; 1978 Jun; 253(12):4481-9. PubMed ID: 659428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Partial purification and characterization of mRNA guanylyltransferase from Saccharomyces cerevisiae.
    Itoh N; Mizumoto K; Kaziro Y
    FEBS Lett; 1983 May; 155(1):161-6. PubMed ID: 6301879
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.